Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 863 M833 M890 M923 M 3.51 B Research & development ———— — Operating income 340 M521 M343 M-195 M 1.01 B Non-Operating Income, Total 4 M-13 M-18 M30 M 3 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 00030 M 30 M Unusual income/expense 4 M-13 M-18 M23 M -4 M Pretax income 212 M367 M189 M278 M 1.05 B Equity in earnings -2 M-2 M-1 M-3 M -8 M Taxes 62 M125 M68 M48 M 303 M Non-controlling/minority interest 38 M49 M32 M51 M 170 M After tax other income/expense ———— — Net income before discontinued operations 112 M193 M89 M179 M 573 M Discontinued operations 0000 0 Net income 112 M193 M89 M179 M 573 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 112 M193 M89 M804 M 1.2 B Basic earnings per share (Basic EPS) 0.20.340.160.33 1.03 Diluted earnings per share (Diluted EPS) 0.20.340.160.33 1.03 Average basic shares outstanding 564.9 M560.6 M554 M556.5 M — Diluted shares outstanding 566.9 M562 M555.7 M558.4 M — EBITDA ———— — EBIT 340 M521 M343 M— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———100 M —